0001808722-23-000001.txt : 20230706 0001808722-23-000001.hdr.sgml : 20230706 20230706135053 ACCESSION NUMBER: 0001808722-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230706 DATE AS OF CHANGE: 20230706 EFFECTIVENESS DATE: 20230706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Actym Therapeutics, Inc. CENTRAL INDEX KEY: 0001808722 IRS NUMBER: 821702886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-486067 FILM NUMBER: 231073020 BUSINESS ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 4156376691 MAIL ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 D 1 primary_doc.xml X0708 D LIVE 0001808722 Actym Therapeutics, Inc. 626 BANCROFT WAY SUITE A BERKELEY CA CALIFORNIA 94710 5102567167 DELAWARE None None Corporation true Christopher D Thanos c/o Actym Therapeutics, Inc. 626 Bancroft Way, Suite A Berkeley CA CALIFORNIA 94710 Executive Officer Director Kanad Das c/o Actym Therapeutics, Inc. 626 Bancroft Way, Suite A Berkeley CA CALIFORNIA 94710 Director Benjamin Chen c/o Actym Therapeutics, Inc. 626 Bancroft Way, Suite A Berkeley CA CALIFORNIA 94710 Director Ron Mazumder c/o Actym Therapeutics, Inc. 626 Bancroft Way, Suite A Berkeley CA CALIFORNIA 94710 Director Julie Cherrington c/o Actym Therapeutics, Inc. 626 Bancroft Way, Suite A Berkeley CA CALIFORNIA 94710 Director Biotechnology Decline to Disclose 06b false 2023-06-28 false true false 0 27539376 11238333 16301043 false 5 0 0 0 false Actym Therapeutics, Inc. /s/ Christopher D Thanos Christopher D Thanos Chief Executive Officer 2023-07-06